FDA authorizes Novavax Covid vaccine targeting JN.1

FDA authorizes Novavax Covid vaccine targeting JN.1

A vial labelled “Novavax V COVID-19 Vaccine” is seen in this illustration taken January 16, 2022.  Dado Ruvic | Reuters The Food and Drug Administration authorized Novavax‘s updated protein-based Covid vaccine for emergency use in people ages 12 and up on Friday, paving the way for the shot to compete with Pfizer and Moderna‘s jabs … Read more

This water treatment startup is already a unicorn

This water treatment startup is already a unicorn

While it might seem like humans and animals consume most of the world’s water, heavy industry uses up to half of it. That’s why business sectors are looking for new ways to recycle water, especially in the face of increased drought. Some of the world’s most essential industries, like pharmaceuticals, food and beverage, textiles, mining, … Read more

New Covid shots from Pfizer, Moderna, what to know

New Covid shots from Pfizer, Moderna, what to know

Moderna Covid-19 Vaccine mRNA 2024-2025 formula. Courtesy: Moderna A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. It’s that time of the year again. A new round of Covid shots is on its way to Americans.  … Read more

U.S. will offer free at-home kits starting late September

U.S. will offer free at-home kits starting late September

Images By Tang Ming Tung | DigitalVision | Getty Images The Biden administration on Friday said it will resume offering free at-home Covid-19 tests to American households in late September as the virus has gained a stronger foothold in the U.S. this summer. Americans will soon be able to use COVIDtests.gov to request four free … Read more

Stocks slide ahead of Powell speech

Stocks slide ahead of Powell speech

Traders work on the floor of the New York Stock Exchange during morning trading on August 12, 2024 in New York City.  Michael M. Santiago | Getty Images News | Getty Images This report is from today’s CNBC Daily Open, our international markets newsletter. CNBC Daily Open brings investors up to speed on everything they … Read more

FDA approves Pfizer, Moderna updated KP.2 shots

FDA approves Pfizer, Moderna updated KP.2 shots

The Food and Drug Administration on Thursday approved updated Covid vaccines from Pfizer and Moderna, putting the new shots on track to reach most Americans in the coming days amid a summer surge of the virus.  The jabs target a strain called KP.2, a descendant of the highly contagious omicron subvariant JN.1 that began circulating … Read more

Combination Covid, flu shot race is heating up

Combination Covid, flu shot race is heating up

A health care worker prepares an injection of Pfizer’s Covid-19 vaccine Comirnaty, Sept. 14, 2023. Irfan Khan | Los Angeles Times | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Good afternoon! Vaccine … Read more

Top Wall Street analysts are bullish on these dividend stocks

Top Wall Street analysts are bullish on these dividend stocks

The U.S. stock market has been under pressure recently due to fears of an economic slowdown, but dividend-paying names can help smooth the ride for investors. Investors can consider the recommendations of top Wall Street analysts as they search for stocks that are backed by strong financials and the ability to pay dividends consistently.    Here … Read more

Drugmakers on new negotiated prices with Medicare

Drugmakers on new negotiated prices with Medicare

President Joe Biden speaks during an event at the National Institutes of Health in Bethesda, Maryland, Dec. 14, 2023. Chris Kleponis | Bloomberg | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! The first round of Medicare drug price negotiations has come … Read more

Moderna (MRNA) earnings Q2 2024

Moderna (MRNA) earnings Q2 2024

Moderna on Thursday reported second-quarter revenue that beat expectations but slashed its full-year sales guidance, citing lower expected sales in Europe, a “competitive environment” for respiratory vaccines in the U.S. and the potential for deferred international revenue into 2025.  The biotech company now expects 2024 product revenue to come in between $3 billion to $3.5 … Read more